Sea Mild Biotechnology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 83.66 million compared to TWD 65.85 million a year ago. Net loss was TWD 18.66 million compared to TWD 31.68 million a year ago. Basic loss per share was TWD 0.97 compared to TWD 1.64 a year ago.